USE OF A GENETIC MODIFICATION IN THE HUMAN GNAQ GENE FOR PREDICTING RISK OF DISEASE, THE COURSE OF A DISEASE, AND REACTION TO TREATMENTS

摘要

In order to determine the risk of disease, the course of a disease, the action of medicaments, the side-effects of medicaments and drug targets, a base substitution is identified in the non-translated region 5' of the gene for the G alpha q sub-unit of human G proteins, preferably the presence of two or three of the polymorphisms GC(-909/-908)TT, G(-382)A or G(-387)A being detected.